...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Expression of mucin-1, galectin-1 and galectin-3 in human leiomyosarcoma in comparison to leiomyoma and myometrium.
【24h】

Expression of mucin-1, galectin-1 and galectin-3 in human leiomyosarcoma in comparison to leiomyoma and myometrium.

机译:与平滑肌瘤和子宫肌层相比,黏蛋白-1,半乳凝素-1和半乳凝素-3在人平滑肌肉瘤中的表达。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The potential mechanism of malignant transformation from leiomyoma to leiomyosarcoma is still debated. The aim was the evaluation of expression patterns of mucin-1 (MUC1) (MUC1 VU-4-H5), galectin-1 (Gal-1) and galectin-3 (Gal-3) in human myometrium and leiomyoma and in comparison to leiomyosarcoma. MATERIALS AND METHODS: Myometrium, leiomyoma and leiomyosarcoma tissues were obtained from 79 patients. Samples were analyzed regarding the expression of MUC1, Gal-1 and Gal-3 by immunohistochemical staining of paraffin-embedded material. RESULTS: The expression of MUC1 (VU4-H5) was up-regulated in leiomyoma (p = 0.065) and leiomyosarcoma (p = 0.039) as compared to the myometrium. In contrast, there were no significant differences in expression of Gal-3 in the tissues from the myometrium, myoma and leiomyosarcoma. Concerning Gal-1 expression, the differences were not significant comparing myometrium and leiomyosarcoma (p = 0.277). Myoma had elevated levels of Gal-1 compared to myometrium (p = 0.007) and leiomyosarcoma (p < 0.0001). CONCLUSION: MUC1 and Gal-1 might be useful for evaluating the potential of leiomyoma to transform into leiomyosarcoma and, therefore, help in risk-adapted consultation and adjusted treatment.
机译:背景:从平滑肌瘤到平滑肌肉瘤的恶性转化的潜在机制仍存在争议。目的是评估粘蛋白-1(MUC1)(MUC1 VU-4-H5),半乳凝素-1(Gal-1)和半乳凝素-3(Gal-3)在人子宫肌层和平滑肌瘤中的表达模式,并与之比较平滑肌肉瘤。材料与方法:取自79例患者的子宫肌层,平滑肌瘤和平滑肌肉瘤组织。通过石蜡包埋材料的免疫组织化学染色分析了有关MUC1,Gal-1和Gal-3表达的样品。结果:与肌层相比,平滑肌瘤(p = 0.065)和平滑肌肉瘤(p = 0.039)中MUC1(VU4-H5)的表达上调。相反,在子宫肌层,肌瘤和平滑肌肉瘤的组织中,Gal-3的表达没有显着差异。关于Gal-1表达,比较子宫肌层和平滑肌肉瘤,差异不显着(p = 0.277)。与肌层(p = 0.007)和平滑肌肉瘤(p <0.0001)相比,肌瘤的Gal-1水平升高。结论:MUC1和Gal-1可能有助于评估平滑肌瘤转化为平滑肌肉瘤的可能性,因此有助于风险适应性咨询和调整治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号